← All patents

US10577344B2

Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

University of Texas System

Abstract

The described invention provides small molecule anti-cancer compounds that selectively target and inhibit measurable biological activity of truncated APC proteins, an immortalized Human Colonic Epithelial Cell (HCEC) model, and pharmaceutical compositions comprising at least one of the small …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Jef DeBrabander
Priority date
September 10, 2013
Filing date
November 27, 2017
Grant date
March 03, 2020
Publication date
March 03, 2020
Language
en
Metadata fetched
August 29, 2026 00:26